| |
| |
|
| Insider
Information: |
Bischofberger Norbert W |
| Relationship: |
Director |
| City: |
Foster City |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
3 |
|
| Direct
Shares |
2,846,606 |
|
|
Indirect Shares
|
10,748,416 |
|
|
| Direct
Value |
$1,245,903 |
|
|
|
Indirect Value
|
$147,319,368 |
|
|
| Total
Shares |
13,595,022 |
|
|
| Total
Value |
$148,565,271 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Gilead Sciences Inc |
GILD |
EVP, R&D and CSO |
2018-02-21 |
19,602 |
2018-02-21 |
2,317,800 |
Premium* |
|
|
Kronos Bio, Inc. |
KRON |
|
2024-06-12 |
2,811,004 |
2024-06-12 |
8,430,616 |
Premium* |
|
|
Vir Biotechnology, Inc. |
VIR |
Director |
2024-05-29 |
16,000 |
2024-05-29 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
196 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 4 of 8
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| GILD |
Gilead Sciences Inc |
officerTitle |
• – – |
2003-08-05 |
4 |
S |
$62.56 |
$3,483,530 |
D/D |
(55,020) |
182,058 |
|
- |
|
| GILD |
Gilead Sciences Inc |
SVP, Research |
• – – |
2004-02-05 |
4 |
OE |
$5.63 |
$398,749 |
D/D |
59,200 |
244,258 |
|
- |
|
| GILD |
Gilead Sciences Inc |
SVP, Research |
• – – |
2004-08-11 |
4 |
S |
$65.52 |
$3,936,875 |
D/D |
(60,000) |
207,058 |
|
- |
|
| GILD |
Gilead Sciences Inc |
SVP, Research |
• – – |
2004-05-05 |
4 |
OE |
$9.50 |
$617,500 |
D/D |
65,000 |
267,058 |
|
- |
|
| GILD |
Gilead Sciences Inc |
SVP, Research |
• – – |
2004-05-05 |
4 |
S |
$58.30 |
$3,790,400 |
D/D |
(65,000) |
202,058 |
|
- |
|
| GILD |
Gilead Sciences Inc |
SVP, Research |
• – – |
2004-08-11 |
4 |
OE |
$6.53 |
$908,285 |
D/D |
65,000 |
267,058 |
|
- |
|
| GILD |
Gilead Sciences Inc |
EVP, R&D and CSO |
• – – |
2015-07-15 |
4 |
AS |
$117.72 |
$7,832,152 |
D/D |
(66,261) |
168,907 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
EVP, R&D and CSO |
• • – |
2016-02-16 |
4 |
A |
$0.00 |
$0 |
D/D |
67,240 |
232,656 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
EVP, R&D and CSO |
• – – |
2015-01-15 |
4 |
OE |
$16.40 |
$1,147,650 |
D/D |
70,000 |
189,302 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
EVP, R&D and CSO |
• – – |
2015-01-15 |
4 |
AS |
$97.81 |
$6,893,083 |
D/D |
(70,000) |
119,302 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
EVP, R&D and CSO |
• – – |
2015-02-17 |
4 |
OE |
$16.40 |
$1,147,650 |
D/D |
70,000 |
235,168 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
EVP, R&D and CSO |
• – – |
2015-02-17 |
4 |
AS |
$102.65 |
$7,210,740 |
D/D |
(70,000) |
165,168 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
EVP, R&D and CSO |
• – – |
2015-03-16 |
4 |
AS |
$100.36 |
$7,056,206 |
D/D |
(70,000) |
165,168 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
EVP, R&D and CSO |
• – – |
2015-03-16 |
4 |
OE |
$16.40 |
$1,364,900 |
D/D |
70,000 |
235,168 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
EVP, R&D and CSO |
• – – |
2015-04-15 |
4 |
OE |
$20.74 |
$1,451,800 |
D/D |
70,000 |
235,168 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
EVP, R&D and CSO |
• – – |
2015-04-15 |
4 |
AS |
$103.06 |
$7,268,627 |
D/D |
(70,000) |
165,168 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
EVP, R&D and CSO |
• – – |
2015-05-15 |
4 |
OE |
$20.74 |
$1,493,550 |
D/D |
70,000 |
235,168 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
EVP, R&D and CSO |
• – – |
2015-05-15 |
4 |
AS |
$109.12 |
$7,661,533 |
D/D |
(70,000) |
165,168 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
EVP, R&D and CSO |
• – – |
2015-06-15 |
4 |
AS |
$116.98 |
$8,237,002 |
D/D |
(70,000) |
165,168 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
EVP, R&D and CSO |
• – – |
2015-06-15 |
4 |
OE |
$21.58 |
$1,510,250 |
D/D |
70,000 |
235,168 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
EVP, R&D and CSO |
• – – |
2015-07-15 |
4 |
OE |
$21.58 |
$1,510,250 |
D/D |
70,000 |
235,168 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
EVP, R&D and CSO |
• – – |
2015-08-17 |
4 |
OE |
$21.58 |
$1,550,750 |
D/D |
70,000 |
235,168 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
EVP, R&D and CSO |
• – – |
2015-08-17 |
4 |
AS |
$115.70 |
$8,131,019 |
D/D |
(70,000) |
165,168 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
EVP, R&D and CSO |
• – – |
2015-09-15 |
4 |
OE |
$23.60 |
$1,652,000 |
D/D |
70,000 |
235,168 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
EVP, R&D and CSO |
• – – |
2015-09-15 |
4 |
AS |
$109.60 |
$7,749,195 |
D/D |
(70,000) |
165,168 |
0 |
- |
|
196 Records found
|
|
Page 4 of 8 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
